HeartRhythm

APRIL 30, 2024

After improvements in pharmacological and surgical treatment options, most patients can be treated effectively without an implantable cardioverter-defibrillator (ICD).

Defibrillator 40

Defibrillator Pharmacology Tachycardia 40

HeartRhythm

APRIL 30, 2024

Because there is no disease-modifying therapeutic to date, the mainstay treatment remains the implantable cardioverter defibrillator, which is associated with significant adverse events.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

Circulation

NOVEMBER 11, 2024

Background:In out-of-hospital cardiac arrest (OHCA) patients with an initial shockable rhythm, epinephrine increases the likelihood of return of spontaneous circulation (ROSC), but its effect on neurological outcome remains uncertain.

Cardiac Arrest 40

Cardiac Arrest Hospital Outcomes Pharmacology 40

Cardiometabolic Health Congress

AUGUST 30, 2024

Pharmacological Interventions : Use of antihypertensive medications, lipid-lowering agents, and antidiabetic drugs. Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

Dr. Smith's ECG Blog

OCTOBER 23, 2023

She was successfully revived after several rounds of ACLS including defibrillation and amiodarone. This may result from fluctuations in heart rate or in nervous system activity or from pharmacologic treatment. By EMS report, open pill bottles were found nearby at the scene, including quetiapine, fluoxetine, hydroxyzine, and gabapentin.

Tachycardia 130

Tachycardia Cardiac Arrest ICU Blog 130

HeartRhythm

FEBRUARY 8, 2025

Pharmacological treatments, including quinidine, cilostazol, and bepridil, offer alternative approaches for VF prevention, particularly for patients experiencing recurrent VF after implantable cardioverter defibrillator (ICD) implantation.1

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology Defibrillator 40

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52